- •Clinical pharmacist-led app significantly promoted GDM women’s medication compliance.
- •Clinical pharmacist-led app improved GDM women’s insulin injection technique.
- •Clinical pharmacist-led app reduced their insulin requirement during pregnancy.
- •Well antepartum and puerperal glycemic control were observed after app intervention.
- •App usage was related to a 22.9% reduction in Neonatal Intensive Care Unit admission.
To investigate the efficacy of a clinical pharmacist-led smartphone application (app) on medication adherence, insulin injection technique (IIT) and diabetes-related outcomes among women with gestational diabetes mellitus (GDM) receiving insulin therapy.
In all, 124 women were randomly (1:1 ratio) assigned to receive app intervention plus usual care (intervention) or usual care (control), and were followed up till 12 weeks postpartum. Interventions centralized on medication adherence and IIT. Primary outcome was medication adherence assessed by the 5-item Medication Adherence Report Scale. Secondary outcomes included IIT, insulin requirement, prepartal and puerperal glycemic control, hypoglycemia, and pregnancy and neonatal outcomes.
A total of 119 patients completed the follow-up evaluation (58 intervention, 61 control). Significant more women with high medication adherence in the intervention group was observed (69.0% vs. 34.4%, p = 0.000). The other notable benefits (all p < 0.05) included patient percentage with appropriate IIT, lesser preprandial insulin dose, patient proportion with both qualified prepartal FPG and 2 hPG, and puerperal FPG or HbA1c, fewer hypoglycemia, and lower neonatal intensive care unit (NICU) admission rate. Cesarean delivery rate was higher among intervention cases (p < 0.05). Qualified prepartal glycemic control was related to high medication adherence and proper IIT. NICU admission was associated with complicated with gestational hypertension, deficient medication adherence and premature rupture of fetal membrane.
Combined with usual care, clinical pharmacist-led smartphone app might be a valid tool for GDM management.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Primary Care Diabetes
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.Cochrane Database Syst. Rev. 2018; 8CD012327
- Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis.J. Diabetes Investig. 2019; 10: 154-162
- Barriers of adherence and possible solutions to Nonadherence to antidiabetic therapy in women with diabetes in pregnancy: patients’ perspective.J. Diabetes Res. 2017; 3578075
- Comparing the efficacy of a mobile phone-based blood glucose management system with standard clinic care in women with gestational diabetes: randomized controlled trial.JMIR Mhealth Uhealth. 2018; 6: e71
- The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial.Am. J. Obstet. Gynecol. 2018; 218 (453.e1–453.e7)
- Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus.J. Endocrinol. Invest. 2019; 42: 709-714
- A randomized controlled trial to evaluate the effects of a smartphone application-based lifestyle coaching program on gestational weight gain, glycemic control, and maternal and neonatal outcomes in women with gestational diabetes mellitus: the SMART-GDM study.Diabetes Care. 2021; 44: 456-463
- Pharmaceutical care of patients with gestational diabetes mellitus.J. Eval. Clin. Pract. 2008; 14: 131-140
- Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan.Int. J. Clin. Pharm. 2018; 40: 48-55
- A stewardship intervention program for safe medication management and use of antidiabetic drugs.Clin. Interv. Aging. 2015; 10: 1201-1212
- Facilitating the safe use of insulin pens in hospitals through a mentored quality-improvement program.Am. J. Health. Syst. Pharm. 2016; 73: S17-31
- Classification and diagnosis of diabetes mellitus.Diabetes Care. 2015; 38: S8-S16
Continuing Medical Care App. http://www.alensic.com/. (Accessed 20 December 2015).
- Adherence to antidiabetic medications among women with gestational diabetes.J. Diabetes Res. 2021; 9941538
- Interventions to improve medication adherence: a review.JAMA. 2018; 320: 2461-2473
- Impact of pharmacist insulin injection re- education on glycemic control among type II diabetic patients in primary health clinics.Saudi Pharm. J. 2021; 29: 670-676
- Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010.Curr. Med. Res. Opin. 2014; 30: 1087-1093
- Obstetric and perinatal outcomes among women with blood- and injection phobia during pregnancy.J. Affect. Disord. 2011; 129: 289-295
- Insulin for the treatment of women with gestational diabetes.Cochrane Database Syst. Rev. 2017; 11CD012037
- Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy.Diabetes Care. 1992; 15: 1323-1327
- Evaluation of an intrapartum insulin regimen for women with diabetes.Obstet. Gynecol. 2020; 136: 411-416
- Using mobile phone text messages to improve insulin injection technique and glycaemic control in patients with diabetes mellitus: a multi-centre study in Turkey.J. Clin. Nurs. 2015; 24: 1525-1533
- The successful rapid adjustment of blood glucose in a patient with acute coronary syndrome, renal insufficiency, and diabetes: a case report of management coordinated by clinical pharmacists and clinicians.Front. Pharmacol. 2020; 11: 756
- Masked hypoglycemia in pregnancy.J. Diabetes. 2017; 9: 778-786
- Associations of dietetic management with maternal and neonatal health outcomes in women diagnosed with gestational diabetes: a retrospective cohort study.J. Hum. Nutr. Diet. 2019; 32: 728-736
- Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation.Am. J. Obstet. Gynecol. 2007; 197 (406.e1–7)
- Antibiotics and the management of preterm premature rupture of the fetal membranes.Clin. Perinatol. 2001; 28: 807-818
- Timing of delivery and pregnancy outcomes in women with gestational diabetes.Am. J. Obstet. Gynecol. 2016; 215 (243.e1–7)
- Cesarean delivery on maternal request in southeast China.Obstet. Gynecol. 2008; 111: 1077-1082
- Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital.Chin Med J (Engl). 2021; 134: 1317-1323
Published online: February 12, 2022
Accepted: February 6, 2022
Received in revised form: February 4, 2022
Received: November 1, 2021
© 2022 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.